allure belle llc
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for allure belle llc from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 24 transactions, with a transaction quantity of 1001300 and a transaction weight of 1001300.
- Year Transactions Quantity Weight
- 2025 15 774553 774553
- 2026 24 1001300 1001300
Bill of lading data
< 1/15 >- Trade date 2026/05/29 B/L No. 91035030739762
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 52700kg Amount 42971.4
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description . MARCA COMERCIAL. NEPHROXA. REFERENCIA. SF CL 230D. PRINCIPIO ACTIVO. CLORURO DE SODIO CLORURO DE POTASIO CLORURO DE CALCIO CLORURO DE MAGNESIO ACIDO CITRICO DEXTROSA.. CONCENTRACION. CLORURO DE SODIO 210 67G L CLORURO DE POTASIO 5.22 CLORURO DE MAGNESIO 3.56 G L CLORURO DE CALCIO 7.72G L ACIDO CITRICO 5.66 G L DEXTROSA 35 G L.. INDICACIONES TERAPEUTICAS. PRODUCTO INDICADO EN LOS CASOS EN DONDE LA DIALISIS ES REQUERIDA INCLUYENDO. Expand
- Trade date 2026/05/29 B/L No. 91035030739834
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 26350kg Amount 20810.3
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO PEL.20266838 SUB DO.40261001 PED. PO 6.2 INDIA DIM 1 1 (942 NAR26 350.00 KG) PRODUCTO. DRY CITRATE TYPE ACID CON Expand
- Trade date 2026/05/13 B/L No. 91035030571096
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 52700kg Amount 42971.4
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description G L CLORURO DE CALCIO 7.72G L ACIDO CITRICO 5.66 G L DEXTROSA 35 G L ACETATO DE SODIO 1.50 G L. INDICACIONES TERAPEUTICAS. PRODUCTO INDICADO ENLOS CASOS EN DONDE LA DIALISIS ES REQUERIDA INCLUYENDO. FALLA RENAL AGUDA O CRONICA RETENCION DE AGUA SEVERA DESEQUILIBRIO ELECTROLITICO GRAVE INTOXICACIONES MEDICAMENTOSAS CON SUSTANCIAS DIALIZABLES CUANDO NOSE DISPONE DE UNA ALTERNATIVA TERAPEUTICA MAS ADECUADA.. FORMA FARMACEUTICA. POLVO BLANCO. TIPO DE EMPAQUE. CAJA POR 8 BOLSAS. CAJA QUE CONTIENEBOLSAS Expand
- Trade date 2026/05/08 B/L No. 91035030524295
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 52700kg Amount 42971.4
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description O CRONICA RETENCION DE AGUA SEVERA DESEQUILIBRIO ELECTROLITICO GRAVE. INTOXICACIONES MEDICAMENTOSAS CON SUSTANCIAS DIALIZABLES CUANDO NO SE DISPONE DE UNA ALTERNATIVA TERAPEUTICA MAS ADECUADA.. REFERENCIA. 35X FORMULA NO. 51. WITH DEXTROSE 210 67 G L NEPHROXAPART A 35X ( 3K 2.5 CA )100 L MIX (ACIDO) (978 UNDS 26350 KGS LOTE. DC2526200 FECHA DE VENCIMIENTO 31 01 2028) (978 UNDS 26350 KGS LOTE. DC2526211 FECHA DE VENCIMIENTO 31 01 2028). NUMERO VB VINVIMA 25 0169811 DE 2025 12 03 RS 2024DM 0028476 EXPEDIENTE. 20254023. REGISTRO 50228905 DE 2025 12 04. PARA EFECTO DEL IVA NOS ACOGEMOS AL (ESTATUTO TRIBUTARIO) DECRETO EXTRAORDINARIO 624 DE 1989 Expand
- Trade date 2026/05/08 B/L No. 91035030524224
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 105400kg Amount 85942.8
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DEXTROSE 210 67 G L NEPHROXAPART A 35X ( 3K 2.5CA ) 100 L MIX (ACIDO) (978 UNDS 26350 KG LOTE DC2526196 FECHA DE VENCIMIENTO 31 12 2027) (1956 UNDS 52700 KGS LOTE DC2526199 FECHA DE VENCIMIENTO 31 01 2028) (978 UNDS 26350 KGS DC2526200 FECHA DE VENCIMIENTO 31 01 2028) . NUMERO VB VINVIMA 25 0169811 DE 2025 12 03 RS 2024DM 0028476 EXPEDIENTE. 20254023. REGISTRO 50228905 DE 2025 12 04. PARA EFECTO DEL IVA NOS ACOGEMOS AL (ESTATUTO TRIBUTARIO) DECRETO Expand
- Trade date 2026/05/07 B/L No. 91035030511408
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 26350kg Amount 21485.7
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description TYPE ACID CONCENTRATE PART A CONCENTRADO SECO PARA HEMODIALISIS TIPO CITRATO EN POLVO PARTE A.. NOMBRE COMERCIAL. NEPHROXA ACID CONCENTRATE PART A 35X (2K 3.00CA) FORMULA NO. 51 CODIGO. SF CL 230D . MARCA COMERCIAL. NEPHROXA. REFERENCIA.SF CL 230D. PRINCIPIO ACTIVO. CLORURO DE SODIO CLORURO DE POTASIO CLORURO DE CALCIO CLORURO DE MAGNESIO ACIDO CITRICO DEXTROSA. . CONCENTRACION. CLORURODE SODIO 210 67 G L CLORURO DE POTASIO 5.22 CLORURO DE MAGNESIO 3.56 G L CLORURO DE CALCIO 7.72G L ACIDO CITRICO 5.66 G L DEXTROSA 35 G L ACETATO DE SODIO 1.50 G L. INDICACIONES TERAPEUTICAS. PRODUCTO INDICADOEN LOS CASOS EN DONDE LA DIALISIS ES REQUERIDA INCLUYENDO. FALLA RENALAGUDA O CRONICA Expand
- Trade date 2026/04/22 B/L No. 91035030388078
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 52700kg Amount 42971.4
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO-PEL.20264542 SUB-DO.40260713 PED. PO 5.1 - INDIA DIM 1/1 // (1,956 NAR 52,700.00 KG) PRODUCTO. DRY CITRATE TYPE ACID Expand
- Trade date 2026/04/22 B/L No. 91035030388861
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 52700kg Amount 42971.4
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO-PEL.20264546 SUB-DO.40260715 PED. PO 5.2 - INDIA DIM 1/1 // (1,956 NAR 52,700.00 KG) PRODUCTO. DRY CITRATE TYPE ACID Expand
- Trade date 2026/04/22 B/L No. 91035030389789
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 52700kg Amount 42971.4
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO-PEL.20264544 SUB-DO.40260714 PED. PO 5.3 - INDIA DIM 1/1 // (1,956 NAR 52,700.00 KG) PRODUCTO. DRY CITRATE TYPE ACID Expand
- Trade date 2026/04/22 B/L No. 91035030388845
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 52700kg Amount 42971.4
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO-PEL.20264549 SUB-DO.40260716 PED. PO 5.4 - INDIA DIM 1/1 // (1,956 NAR 52,700.00 KG) PRODUCTO. DRY CITRATE TYPE ACID Expand
- Trade date 2026/04/08 B/L No. 91035030252302
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 52700kg Amount 42971.4
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO-PEL.20263304 SUB-DO.40260512 PED. PO 4.4 INDIA DIM 11 (1,956 NAR 52,700.00 KG) PRODUCTO. DRY CITRATE TYPE ACID Expand
- Trade date 2026/04/08 B/L No. 91035030252366
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 26350kg Amount 21485.7
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO-PEL.20264035 SUB-DO.40260630 PED. PO 4.7 DIM 11 (978 NAR 26,350.00 KG) PRODUCTO. DRY CITRATE TYPE ACID CONCENTRAT Expand
- Trade date 2026/04/08 B/L No. 91035030252334
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 26350kg Amount 21485.7
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO-PEL.20264014 SUB-DO.40260629 PED. PO 4.6 INDIA DIM 11 (978 NAR26,350.00 KG) PRODUCTO. DRY CITRATE TYPE ACID CON Expand
- Trade date 2026/03/31 B/L No. 91035030190025
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 26350kg Amount 21485.7
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO-PEL.20263306 SUB-DO.40260514 PED. PO 4.3 INDIA DIM 11 (978 NAR26,350.00 KG) PRODUCTO. DRY CITRATE TYPE ACID CON Expand
- Trade date 2026/03/31 B/L No. 91035030190143
- Suppliers allure belle llc Buyers gls health y biotechnology s.a.
- POLs —— PODs buenaventura
- Supply area United States Purchas area Colombia
- Weight 26350kg Amount 21485.7
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO-PEL.20263309 SUB-DO.40260515 PED. PO 4.2 INDIA DIM 11 (978 NAR26,350.00 KG) PRODUCTO. DRY CITRATE TYPE ACID CON Expand
Partners
Total 2- Rank Company Transactions Per Detail
- 1 gls health y biotechnology s.a. colombiabuyer,they trade on 2026-05-29 39 97.50% >
- 2 gls health biotechnology s.a. colombiabuyer,they trade on 2024-07-09 1 2.50% >
Products
Total 1- Products Transactions Per Detail
-
equipped with fixed dose drug
1 100% >
Hscode rank
Total 1- HSCode Name Transactions Per Detail
- HS 3004902900 1 100% >
Trading Area
Total 1- Area Transactions Per Detail
- colombia 40 100.00% >
allure belle llc is united states Supplier,
and primarily engages in the import and export business of products such as equipped with fixed dose drug.
According to the 52wmb.com global trade database, as of 2026-05-29, the company has completed 40 international trades,
with its main trading regions covering colombia etc.
The core products include HS3004902900 etc,
and its main trading partners are gls health y biotechnology s.a.，gls health biotechnology s.a..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on allure belle llc is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool